Paris, France

Cecile Bauche

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cecile Bauche

Introduction

Cecile Bauche is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vector particles. With a total of seven patents to her name, her work has advanced the understanding and application of gene delivery systems.

Latest Patents

Cecile Bauche's latest patents include innovative methods and compositions related to lyophilized lentiviral vector particles. One of her notable inventions provides methods for making these particles, along with compositions that comprise them. Additionally, she has developed methods for administering lentiviral vector particles to subjects, enhancing their therapeutic potential. Another significant patent focuses on the use of adenylcyclase toxin in manufacturing vectors that target CD11b expressing cells. This invention not only introduces a novel delivery mechanism but also includes immunogenic compositions that prime immune responses.

Career Highlights

Throughout her career, Cecile has worked with esteemed organizations such as Theravectys and the Institut Pasteur. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Cecile has collaborated with notable colleagues, including Emeline Sarry and Claude Leclerc. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in her innovative projects.

Conclusion

Cecile Bauche's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence advancements in gene therapy and molecular delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…